Trinity Biotech (TRIB) Competitors $0.70 +0.02 (+2.71%) Closing price 08/1/2025 03:57 PM EasternExtended Trading$0.70 0.00 (-0.35%) As of 08/1/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRIB vs. AADI, EGRX, PEPG, JSPR, RNXT, CVM, LTRN, NBRV, ACRV, and OVIDShould you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Aadi Bioscience (AADI), Eagle Pharmaceuticals (EGRX), PepGen (PEPG), Jasper Therapeutics (JSPR), RenovoRx (RNXT), CEL-SCI (CVM), Lantern Pharma (LTRN), Nabriva Therapeutics (NBRV), Acrivon Therapeutics (ACRV), and Ovid Therapeutics (OVID). These companies are all part of the "pharmaceutical products" industry. Trinity Biotech vs. Its Competitors Aadi Bioscience Eagle Pharmaceuticals PepGen Jasper Therapeutics RenovoRx CEL-SCI Lantern Pharma Nabriva Therapeutics Acrivon Therapeutics Ovid Therapeutics Aadi Bioscience (NASDAQ:AADI) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends. Which has stronger valuation & earnings, AADI or TRIB? Trinity Biotech has higher revenue and earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAadi Bioscience$25.07M1.71-$65.76M-$2.35-0.74Trinity Biotech$61.56M0.21-$31.79M-$2.93-0.24 Do analysts rate AADI or TRIB? Aadi Bioscience currently has a consensus target price of $1.67, suggesting a potential downside of 4.21%. Given Aadi Bioscience's stronger consensus rating and higher possible upside, equities research analysts clearly believe Aadi Bioscience is more favorable than Trinity Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Trinity Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor AADI or TRIB? In the previous week, Aadi Bioscience's average media sentiment score of 0.00 equaled Trinity Biotech'saverage media sentiment score. Company Overall Sentiment Aadi Bioscience Neutral Trinity Biotech Neutral Which has more volatility & risk, AADI or TRIB? Aadi Bioscience has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Do insiders and institutionals hold more shares of AADI or TRIB? 52.1% of Aadi Bioscience shares are owned by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are owned by institutional investors. 37.3% of Aadi Bioscience shares are owned by company insiders. Comparatively, 8.2% of Trinity Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is AADI or TRIB more profitable? Trinity Biotech has a net margin of -68.48% compared to Aadi Bioscience's net margin of -246.06%. Trinity Biotech's return on equity of 0.00% beat Aadi Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Aadi Bioscience-246.06% -71.87% -57.28% Trinity Biotech -68.48%N/A -32.33% SummaryTrinity Biotech beats Aadi Bioscience on 8 of the 13 factors compared between the two stocks. Get Trinity Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRIB vs. The Competition Export to ExcelMetricTrinity BiotechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.38M$10.40B$5.48B$9.53BDividend YieldN/A1.99%4.73%4.09%P/E Ratio-0.2418.7328.8923.83Price / Sales0.2129.01371.1466.13Price / CashN/A22.3135.4557.96Price / Book-0.363.478.265.54Net Income-$31.79M$234.77M$3.25B$259.28M7 Day Performance5.07%-4.82%-3.73%-4.67%1 Month Performance3.60%1.80%4.28%4.37%1 Year Performance-74.10%-12.51%25.85%17.90% Trinity Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRIBTrinity Biotech1.0228 of 5 stars$0.70+2.7%N/A-75.3%$12.38M$61.56M-0.24480Gap UpAADIAadi Bioscience0.4789 of 5 stars$1.95+0.5%$1.67-14.5%+15.1%$48.16M$25.07M-0.8640Upcoming EarningsGap UpEGRXEagle Pharmaceuticals1.978 of 5 stars$3.69flatN/A-33.3%$47.92M$257.55M0.00100Gap DownPEPGPepGen2.6573 of 5 stars$1.43-1.4%$7.67+436.1%-86.9%$47.44MN/A-0.4630JSPRJasper Therapeutics2.7052 of 5 stars$3.10-1.6%$29.75+859.7%-83.4%$47.32MN/A-0.5920RNXTRenovoRx2.3416 of 5 stars$1.25-1.6%$7.25+480.0%-1.6%$46.45M$40K-3.136Analyst DowngradeGap UpCVMCEL-SCI1.1164 of 5 stars$8.66+5.6%N/A-72.6%$46.08MN/A-18.0443Positive NewsShort Interest ↑High Trading VolumeLTRNLantern Pharma2.2609 of 5 stars$4.01-5.4%$25.00+523.4%+17.5%$45.67MN/A-2.1820News CoverageUpcoming EarningsShort Interest ↑Gap DownNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ACRVAcrivon Therapeutics2.7867 of 5 stars$1.43flat$17.71+1,138.8%-83.9%$44.84MN/A-0.6458OVIDOvid Therapeutics4.3464 of 5 stars$0.53-14.7%$3.13+492.4%-49.5%$43.98M$570K-1.5160Gap Down Related Companies and Tools Related Companies Aadi Bioscience Competitors Eagle Pharmaceuticals Competitors PepGen Competitors Jasper Therapeutics Competitors RenovoRx Competitors CEL-SCI Competitors Lantern Pharma Competitors Nabriva Therapeutics Competitors Acrivon Therapeutics Competitors Ovid Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRIB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRIB Stock Alerts